Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening for EGFR mutations in lung cancer, a report from India.

Lung cancer (Amsterdam, Netherlands) - 1 Sept 2011

Sahoo Rashmita, Harini V Vidya, Babu V Chitti, Patil Okaly Geeta V, Rao Smitha, Nargund Ashwini, Venkataswamy E, Rao Raghavendra, Kumar B S Ajai

Abstract excerpt

Epidermal growth factor receptor (EGFR) is one of the targeted molecular markers in many cancers including the lung malignancy. Genetic modifications such as deletions, insertions and Single Nucleotide Polymorphisms in the tyrosine kinase (TK) domain of EGFR is a common feature observed in most lung cancers. Gefitinib and erlotinib are commonly available therapeutic drugs which act as specific inhibitors for the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Erlotinib Hydrochloride

Share to Gefitinib

Share to Quinazolines

Share to Sequence Deletion

Share to Sex Factors

Source

Identifiers

PMID: 21315473
DOI: 10.1016/j.lungcan.2011.01.004

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening for EGFR mutations in lung cancer, a report from India.PMID 21315473Read ↗

Epidermal growth factor receptor mutation in non-small-cell lung carcinomas: a retrospective analysis of 1036 lung cancer specimens from a network of tertiary cancer care centers in India.Semantic proximity Read ↗

Mutational Analysis of EGFR Mutations in Non-Small Cell Lung Carcinoma-An Indian Perspective of 212 Patients.Semantic proximity Read ↗

Molecular epidemiology of epidermal growth factor receptor mutations in lung cancers in Indian population.Semantic proximity Read ↗

Epidermal growth factor receptor mutation in lung adenocarcinoma in India: A single center studySemantic proximity Read ↗

Epidermal growth factor receptor mutation subtypes and geographical distribution among Indian non-small cell lung cancer patients.Semantic proximity Read ↗

Frequency of EGFR mutations in lung adenocarcinoma patients - A study from tertiary cancer center of South India.Semantic proximity Read ↗

EGFR mutations and ROS1 and ALK rearrangements in a large series of non-small cell lung cancer in South India.Semantic proximity Read ↗

Incidence and characteristics of Epidermal Growth Factor Receptor (EGFR) mutation in non-small-cell lung cancer (Adenocarcinoma histology): A report of 106 patients from Kolkata.Semantic proximity Read ↗

The prevalence and clinical significance of EGFR mutations in non-small cell lung cancer patients in Egypt: a screening study.Semantic proximity Read ↗

Distribution of EGFR mutations commonly observed in primary lung adenocarcinomas in Pakistan as predictors for targeted therapy.Semantic proximity Read ↗

Epidermal growth factor receptor mutations in adenocarcinoma lung: Comparison of techniques for mutation detection.Semantic proximity Read ↗

EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.